Page last updated: 2024-08-23

dobutamine and cyclic gmp

dobutamine has been researched along with cyclic gmp in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's5 (45.45)18.2507
2000's5 (45.45)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumann, G; Gerzer, R; Stangl, K; Weil, J1
Eskinder, H; Gross, GJ1
Armstead, WM; Devine, JO; Rebich, S1
Satake, N; Shibata, S; Zhou, Q1
Balligand, JL; Colucci, WS; Hare, JM; Keaney, JF; Loscalzo, J; Smith, TW1
Du Toit, EF; McCarthy, J; Muller, CA; Opie, LH1
Hisaoka, T; Kobayashi, S; Kohno, M; Matsuzaki, M; Mochizuki, M; Ohkusa, T; Ono, K; Tanigawa, T; Yamada, J; Yano, M1
Burnett, JC; Hahn, EL; Hart, CY; Meyer, DM; Redfield, MM1
Hare, JM; Isoda, T; Juang, GJ; Kass, DA; Mayer, SP; Ohler, A; Paolocci, N; Senzaki, H; Smith, CJ; Tomaselli, GF1
Frantz, S; Kelly, RA; Paulus, WJ1
Barclay, JK; Reading, SA1

Other Studies

11 other study(ies) available for dobutamine and cyclic gmp

ArticleYear
Acute effects of beta-adrenergic stimulation with dobutamine on the plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with chronic heart failure.
    European heart journal, 1991, Volume: 12, Issue:8

    Topics: Aged; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Chronic Disease; Cyclic GMP; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Male; Middle Aged

1991
8-Bromo cyclic GMP mimics the actions of nitroglycerin in modulating responses produced by full and partial alpha-adrenoceptor agonists in canine saphenous vein.
    European heart journal, 1988, Volume: 9 Suppl A

    Topics: Adrenergic alpha-Agonists; Animals; Cyclic GMP; Dobutamine; Dogs; In Vitro Techniques; Nitroglycerin; Phenylephrine; Saphenous Vein; Vasoconstriction; Vasodilation

1988
Role of nitric oxide and cAMP in beta-adrenoceptor-induced pial artery vasodilation.
    The American journal of physiology, 1995, Volume: 268, Issue:3 Pt 2

    Topics: Albuterol; Amino Acid Oxidoreductases; Animals; Animals, Newborn; Arginine; Colforsin; Cyclic AMP; Cyclic GMP; Dobutamine; Enzyme Activation; Female; Isoproterenol; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Pia Mater; Receptors, Adrenergic, beta; Swine; Vasodilation

1995
Inhibitory effect of sodium nitroprusside on the relaxing action of isoproterenol in isolated rat urinary bladder.
    General pharmacology, 1994, Volume: 25, Issue:4

    Topics: Animals; Cyclic GMP; Dobutamine; Electric Stimulation; In Vitro Techniques; Isoproterenol; Male; Methylene Blue; Muscle Relaxation; Nitroprusside; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Urinary Bladder

1994
Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation.
    The American journal of physiology, 1996, Volume: 271, Issue:6 Pt 2

    Topics: Adrenergic beta-Agonists; Animals; Coronary Vessels; Cyclic GMP; Dobutamine; Dogs; Enzyme Inhibitors; Female; Heart; Injections; Isoproterenol; Male; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ventricular Function

1996
Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:2

    Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Agonists; Calcium Channel Blockers; Cyclic AMP; Cyclic GMP; Dobutamine; Glyburide; Guinea Pigs; Heart; Hydrazones; In Vitro Techniques; L-Lactate Dehydrogenase; Lactic Acid; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nucleotides, Cyclic; Phosphocreatine; Pyridazines; Simendan; Stereoisomerism

1999
Effect of milrinone on left ventricular relaxation and Ca(2+) uptake function of cardiac sarcoplasmic reticulum.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:4

    Topics: Adrenergic beta-Agonists; Animals; Calcium; Calcium-Transporting ATPases; Cardiotonic Agents; Cyclic AMP; Cyclic GMP; Dobutamine; Dogs; Hemodynamics; Milrinone; Myocardium; Phosphodiesterase Inhibitors; Rolipram; Sarcoplasmic Reticulum; Ventricular Function, Left

2000
Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 281, Issue:1

    Topics: Adrenergic beta-Agonists; Animals; Cyclic GMP; Diastole; Dobutamine; Dogs; Drug Synergism; Heart; Heart Failure; Hemodynamics; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Nitric Oxide; Reference Values; Second Messenger Systems; Systole; Ventricular Function, Left

2001
Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:10

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Blood Pressure; Cardiac Output, Low; Colforsin; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dobutamine; Dogs; Female; Heart; Hemodynamics; Immunohistochemistry; Male; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Piperazines; Purines; Purinones; Pyrazoles; Receptors, Adrenergic, beta; Signal Transduction; Sildenafil Citrate; Sulfones

2001
Nitric oxide and cardiac contractility in human heart failure: time for reappraisal.
    Circulation, 2001, Nov-06, Volume: 104, Issue:19

    Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cyclic AMP; Cyclic GMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Failure; Humans; Isoenzymes; Myocardial Contraction; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Substance P; Ventricular Function, Left

2001
The inotropic effect of nitric oxide on mammalian papillary muscle is dependent on the level of beta1-adrenergic stimulation.
    Canadian journal of physiology and pharmacology, 2002, Volume: 80, Issue:6

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Animals; Cats; Cyclic GMP; Dobutamine; Drug Synergism; Electric Stimulation; Endothelium, Vascular; Female; In Vitro Techniques; Isometric Contraction; Male; Myocardial Contraction; Nitric Oxide; Nitric Oxide Donors; Papillary Muscles; S-Nitroso-N-Acetylpenicillamine; Vasodilator Agents

2002